▶ 調査レポート

タミフル(リン酸オセルタミビル)の世界市場:薬物種類別(ブランド、ジェネリック)、剤形別(カプセル、懸濁液)、適応症別(インフルエンザA、インフルエンザB、その他)、流通経路別(病院薬局、小売薬局、オンライン薬局、その他)

• 英文タイトル:Tamiflu (Oseltamivir Phosphate) Market (Drug Type: Branded and Generic; Dosage Form: Capsule and Suspension; Indication: Influenza A, Influenza B, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。タミフル(リン酸オセルタミビル)の世界市場:薬物種類別(ブランド、ジェネリック)、剤形別(カプセル、懸濁液)、適応症別(インフルエンザA、インフルエンザB、その他)、流通経路別(病院薬局、小売薬局、オンライン薬局、その他) / Tamiflu (Oseltamivir Phosphate) Market (Drug Type: Branded and Generic; Dosage Form: Capsule and Suspension; Indication: Influenza A, Influenza B, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / D0JU09139資料のイメージです。• レポートコード:D0JU09139
• 出版社/出版日:Transparency Market Research / 2020年2月19日
• レポート形態:英文、PDF、189ページ
• 納品方法:Eメール
• 産業分類:製薬
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、タミフル(リン酸オセルタミビル)の世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、市場概要、薬物種類別(ブランド、ジェネリック)分析、剤形別(カプセル、懸濁液)分析、適応症別(インフルエンザA、インフルエンザB、その他)分析、流通経路別(病院薬局、小売薬局、オンライン薬局、その他)分析、地域別分析、競争状況などの構成でお届けいたします。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場動向
・市場概要
・タミフル(リン酸オセルタミビル)の世界市場:薬物種類別(ブランド、ジェネリック)
・タミフル(リン酸オセルタミビル)の世界市場:剤形別(カプセル、懸濁液)
・タミフル(リン酸オセルタミビル)の世界市場:適応症別(インフルエンザA、インフルエンザB、その他)
・タミフル(リン酸オセルタミビル)の世界市場:流通経路別(病院薬局、小売薬局、オンライン薬局、その他)
・タミフル(リン酸オセルタミビル)の世界市場:地域別
・競争状況

Tamiflu (Oseltamivir Phosphate) Market – Scope of the Report

TMR’s report on the global Tamiflu (Oseltamivir Phosphate) market studies past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period from 2019 to 2027. The report provides the overall market revenue of the global Tamiflu (Oseltamivir Phosphate) market for the period of 2017 to 2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global Tamiflu (Oseltamivir Phosphate) market for the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involves bulk of research efforts, wherein, analysts carry out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global Tamiflu (Oseltamivir Phosphate) market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approach to study various phenomena in the global Tamiflu (Oseltamivir Phosphate) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global Tamiflu (Oseltamivir Phosphate) market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global Tamiflu (Oseltamivir Phosphate) market.

The report delves into the competitive landscape of the global Tamiflu (Oseltamivir Phosphate) market. Key players operating in the global Tamiflu (Oseltamivir Phosphate) market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global Tamiflu (Oseltamivir Phosphate) market that have been profiled in this report.

Key Questions Answered in Tamiflu (Oseltamivir Phosphate) Market Report

What is the sales/revenue generated by each drug type, dosage form segments of the Tamiflu (Oseltamivir Phosphate) market across all regions during the forecast period?
What are the opportunities in the global Tamiflu (Oseltamivir Phosphate) market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which region is likely to expand at the fastest CAGR during the forecast period?
Which Tamiflu (Oseltamivir Phosphate) indication and distribution channel segments are expected to generate the highest revenue globally in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market share or position of different companies operating in the global market in 2018?
Tamiflu (Oseltamivir Phosphate) Market – Research Objectives and Research Approach

The comprehensive report on the global Tamiflu (Oseltamivir Phosphate) market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, key industrial developments in terms of merger, acquisition, strategic partnerships, influenza flu prevalence globally, and key brand sales over the years at global and different geographies have been provided.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into small sections. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Tamiflu (Oseltamivir Phosphate) market in terms of drug type, dosage form, indication, distribution channel, and region. Key segments under each criteria have been studied at length and the market share for each of them at the end of 2027 has been provided herein. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Tamiflu (Oseltamivir Phosphate) market.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Tamiflu (Oseltamivir Phosphate) Market

4. Market Overview

4.1. Introduction

4.1.1. Drug Type Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

5.1. 5.1.Influenza Flu Prevalence globally

5.2. 5.2.Key Mergers, Acquisition, and Strategic Partnerships

5.3. 5.3.Top Dugs Sales Analysis of Oseltamivir Phosphate brand

6. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast, by Drug Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Drug Type, 2017–2027

6.3.1. Branded

6.3.2. Generic

6.4. Market Attractiveness, by Drug Type

7. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast, by Dosage Form

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Dosage Form, 2017–2027

7.3.1. Capsule

7.3.2. Suspension

7.4. Market Attractiveness, by Dosage Form

8. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast, by Indication

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Indication, 2017–2027

8.3.1. Influenza A

8.3.2. Influenza B

8.3.3. Others

8.4. Market Attractiveness, by Indication

9. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast, by Distribution Channel

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Market Value Forecast, by Distribution Channel, 2017–2027

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Online Pharmacies

9.3.4. Others

9.4. Market Attractiveness, by Distribution Channel

10. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast, by Region

10.1. Key Findings

10.2. Market Value Forecast, by Region

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Market Attractiveness, by Country/Region

11. North America Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Market Value Forecast, by Drug Type, 2017–2027

11.2.1. Branded

11.2.2. Generic

11.3. Market Value Forecast, by Dosage Form, 2017–2027

11.3.1. Capsule

11.3.2. Suspension

11.4. Market Value Forecast, by Indication, 2017–2027

11.4.1. Influenza A

11.4.2. Influenza B

11.4.3. Others

11.5. Market Value Forecast, by Distribution Channel, 2017–2027

11.5.1. Hospital Pharmacies

11.5.2. Retail Pharmacies

11.5.3. Online Pharmacies

11.5.4. Others

11.6. Market Value Forecast, by Country, 2017–2027

11.6.1. U.S.

11.6.2. Canada

11.7. Market Attractiveness Analysis

11.7.1. By Drug Type

11.7.2. By Dosage Form

11.7.3. By Indication

11.7.4. By Distribution Channel

11.7.5. By Country

12. Europe Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value Forecast, by Drug Type, 2017–2027

12.2.1. Branded

12.2.2. Generic

12.3. Market Value Forecast, by Dosage Form, 2017–2027

12.3.1. Capsule

12.3.2. Suspension

12.4. Market Value Forecast, by Indication, 2017–2027

12.4.1. Influenza A

12.4.2. Influenza B

12.4.3. Others

12.5. Market Value Forecast, by Distribution Channel, 2017–2027

12.5.1. Hospital Pharmacies

12.5.2. Retail Pharmacies

12.5.3. Online Pharmacies

12.5.4. Others

12.6. Market Value Forecast, by Country/Sub-region, 2017–2027

12.6.1. Germany

12.6.2. U.K.

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Rest of Europe

12.7. Market Attractiveness Analysis

12.7.1. By Drug Type

12.7.2. By Dosage Form

12.7.3. By Indication

12.7.4. By Distribution Channel

12.7.5. By Country/Sub-region

13. Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast, by Drug Type, 2017–2027

13.2.1. Branded

13.2.2. Generic

13.3. Market Value Forecast, by Dosage Form, 2017–2027

13.3.1. Capsule

13.3.2. Suspension

13.4. Market Value Forecast, by Indication, 2017–2027

13.4.1. Influenza A

13.4.2. Influenza B

13.4.3. Others

13.5. Market Value Forecast, by Distribution Channel, 2017–2027

13.5.1. Hospital Pharmacies

13.5.2. Retail Pharmacies

13.5.3. Online Pharmacies

13.5.4. Others

13.6. Market Value Forecast, by Country/Sub-region, 2017–2027

13.6.1. China

13.6.2. Japan

13.6.3. India

13.6.4. Australia & New Zealand

13.6.5. Rest of Asia Pacific

13.7. Market Attractiveness Analysis

13.7.1. By Drug Type

13.7.2. By Dosage Form

13.7.3. By Indication

13.7.4. By Distribution Channel

13.7.5. By Country/Sub-region

14. Latin America Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Market Value Forecast, by Drug Type, 2017–2027

14.2.1. Branded

14.2.2. Generic

14.3. Market Value Forecast, by Dosage Form, 2017–2027

14.3.1. Capsule

14.3.2. Suspension

14.4. Market Value Forecast, by Indication, 2017–2027

14.4.1. Influenza A

14.4.2. Influenza B

14.4.3. Others

14.5. Market Value Forecast, by Distribution Channel, 2017–2027

14.5.1. Hospital Pharmacies

14.5.2. Retail Pharmacies

14.5.3. Online Pharmacies

14.5.4. Others

14.6. Market Value Forecast, by Country/Sub-region, 2017–2027

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Market Attractiveness Analysis

14.7.1. By Drug Type

14.7.2. By Dosage Form

14.7.3. By Indication

14.7.4. By Distribution Channel

14.7.5. By Country/Sub-region

15. Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

15.1. Introduction

15.1.1. Key Findings

15.2. Market Value Forecast, by Drug Type, 2017–2027

15.2.1. Branded

15.2.2. Generic

15.3. Market Value Forecast, by Dosage Form, 2017–2027

15.3.1. Capsule

15.3.2. Suspension

15.4. Market Value Forecast, by Indication, 2017–2027

15.4.1. Influenza A

15.4.2. Influenza B

15.4.3. Others

15.5. Market Value Forecast, by Distribution Channel, 2017–2027

15.5.1. Hospital Pharmacies

15.5.2. Retail Pharmacies

15.5.3. Online Pharmacies

15.5.4. Others

15.6. Market Value Forecast, by Country/Sub-region, 2017–2027

15.6.1. GCC Countries

15.6.2. South Africa

15.6.3. Rest of Middle East & Africa

15.7. Market Attractiveness Analysis

15.7.1. By Drug Type

15.7.2. By Dosage Form

15.7.3. By Indication

15.7.4. By Distribution Channel

15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player – Competition Matrix (By Tier and Size of companies)

16.2. Market Share Analysis, by Company (2016)

16.3. Company Profiles

16.3.1. F.Hoffmann-La Roche Ltd.

16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.1.2. Company Financials

16.3.1.3. Growth Strategies

16.3.1.4. SWOT Analysis

16.3.2. NATCO Pharma Limited

16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.2.2. Company Financials

16.3.2.3. Growth Strategies

16.3.2.4. SWOT Analysis

16.3.3. Teva Pharmaceutical Industries Ltd.

16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.3.2. Company Financials

16.3.3.3. Growth Strategies

16.3.3.4. SWOT Analysis

16.3.4. LUPIN Limited

16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.4.2. Company Financials

16.3.4.3. Growth Strategies

16.3.4.4. SWOT Analysis

16.3.5. Amneal pharmaceuticals LLC

16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.5.2. Company Financials

16.3.5.3. Growth Strategies

16.3.5.4. SWOT Analysis

16.3.6. Zydus Cadila

16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.6.2. Company Financials

16.3.6.3. Growth Strategies

16.3.6.4. SWOT Analysis

16.3.7. Sun Pharmaceutical Industries Ltd.

16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.7.2. Company Financials

16.3.7.3. Growth Strategies

16.3.7.4. SWOT Analysis

16.3.8. Alembic Pharmaceuticals Limited

16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.8.2. Company Financials

16.3.8.3. Growth Strategies

16.3.8.4. SWOT Analysis

16.3.9. Mylan N.V.

16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.9.2. Company Financials

16.3.9.3. Growth Strategies

16.3.9.4. SWOT Analysis

16.3.10. Hetero Group

16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.10.2. Company Financials

16.3.10.3. Growth Strategies

16.3.10.4. SWOT Analysis

List of Tables

Table 01: Key Mergers, Acquisition, and Strategic Partnerships

Table 02: Top Drugs Sales (US$ Mn) Analysis of Oseltamivir Phosphate brand (Tamiflu) by F.Hoffmann-La Roche Ltd.

Table 03: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2017–2027

Table 04: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 05: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 06: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 07: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 08: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 09: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2017–2027

Table 10: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 11: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2016–2026

Table 12: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 13: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 14: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2017–2027

Table 15: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 16: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2016–2026

Table 17: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 18: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 19: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2017–2027

Table 20: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 21: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2016–2026

Table 22: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 23: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 24: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2017–2027

Table 25: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 26: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2016–2026

Table 27: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 28: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 29: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2017–2027

Table 30: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 31: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2016–2026

Table 32: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027